Pharmacological Potential of Betulin as a Multitarget Compound
Feyisayo O Adepoju1, Kingsley C Duru2, Erguang Li3
1Department of Technology for Organic Synthesis, Chemical Technology Institute, Ural Federal University, Mira 19, 620002 Yekaterinburg, Russia.
Biomolecules
|July 29, 2023
Summary
Betulin, a natural compound from birch bark, shows promise as a multitarget drug. Its anti-inflammatory and other beneficial effects stem from its ability to modulate key signaling pathways like MAPK and NF-κB.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Molecular Biology
Background:
- Betulin is a triterpene isolated from birch bark with known pharmacological activities.
- Existing research highlights betulin's protective effects across various diseases, including cardiovascular and liver conditions, cancer, and diabetes.
- Despite its diverse actions, betulin has not been recognized as a multitarget therapeutic agent.
Purpose of the Study:
- To review the natural sources, pharmacokinetics, and pharmacological activities of betulin.
- To explore the multitarget effects of betulin, particularly its anti-inflammatory actions.
- To investigate betulin's modulation of key signaling pathways such as MAPK, NF-κB, and Nrf2.
Main Methods:
- Literature review of studies on betulin's natural sources and pharmacology.
- Analysis of research detailing betulin's effects on cellular signaling pathways.
- Examination of studies investigating betulin's role in disease models and its impact on oxidative stress and inflammation.
Main Results:
- Betulin exhibits protective effects against cardiovascular and liver diseases, cancer, diabetes, oxidative stress, and inflammation.
- It reduces hyperglycemia by inhibiting alpha-amylase and alpha-glucosidase.
- Betulin combats cancer cells via apoptosis induction and inhibition of metastatic proteins, and modulates inflammation by blocking proinflammatory cytokines through NF-κB and MAPK pathways.
Conclusions:
- Betulin's diverse beneficial effects are partly attributed to its multitarget anti-inflammatory activity.
- Its ability to modulate multiple biological networks with high target specificity suggests potential as a lead compound for drug development.
- Betulin's modulation of MAPK, NF-κB, and Nrf2 pathways underscores its significance in regulating oxidative stress and inflammation.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.6K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.3K
Related Concept Videos
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
01:24Principles of Drug Action
6.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.1K
01:27Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
01:25Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
664
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
664